U.S. law firm Goodwin Procter has hired Edwin Chan as a partner in its private equity practice in Hong Kong from Paul, Weiss, Rifkind, Wharton & Garrison, where he was counsel.

Chan’s practice focuses on private equity transactions, investment restructuring and exits, including cross-border and domestic mergers and acquisitions, joint ventures, growth capital and pre-IPO investments, PIPE, co-investments and structured and special situations investments. He has advised financial sponsors through the lifecycle of their investments in the Asian region.

Prior to joining Paul Weiss in July 2016, Chan was a managing associate at Linklaters. He started his career at Jones Day, and also had a brief stint at Goldman Sachs.

Chan’s hire is Goodwin’s first partner-level lateral in Hong Kong since the firm added life-sciences specialist Wenseng “Wendy” Pan from Sidley Austin in 2019. Goodwin now has 10 partners in Hong Kong.


To contact the editorial team, please email

Related Articles

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

HK: Goodwin adds debt finance expert from White & Case

by Nimitt Dixit |

U.S. law firm Goodwin Procter has made its first Hong Kong partner hire in 2023 with the addition of debt finance attorney Stephen Howard from White & Case, where he was a local partner.

Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition

by Nimitt Dixit |

U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.